Search Results 251-260 of 23015 for Phase

  1. Phase Transitions: Ph.D. Students Explore Real-Time Seizure Detection and Antibiotic Resistance - News Archive

    In this article series, students who are at the end of Ph.D. training at Mayo Clinic Graduate School of Biomedical Sciences share their research experience.

  2. A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma - Mayo Clinic

    Clinical Trials · A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma · More about research at Mayo Clinic · Mayo Clinic ...

  3. Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma - Mayo Clinic

    Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for ...

  4. Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke - Mayo Clinic

    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator (tPA) ...

  5. A Phase 2/3 Study On The Efficacy And Safety Of Mangaciclanol For ContrastEnhanced MRI Of CNS Or Body In Adult Patients - Mayo Clinic

    The purpose of this study is to identify a dose of mangaciclanol for the Phase 3 part of the study that has an overall diagnostic preference similar to that of ...

  6. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

    Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant ...

  7. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

    This randomized phase II trial studies how well irinotecan hydrochloride and cetuximab with or without vemurafenib works in treating patients with colorectal ...

  8. Phase 3. This phase aims to help you eat healthy for life. You focus on eating foods with complex carbs, lean protein and healthy fats. But you can eat ...

  9. A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients With Advanced or Metastatic Renal Cell Carcinoma - Mayo Clinic

    About this study. Phase 1b: To evaluate safety and tolerability and determine a recommended phase 2 dose for TRC105 when added to standard dose axitinib in ...

  10. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.